in vitro to anti-lymphocyte antiserum appropriately absorbed with both bone marrow and fetal liver cells to render it nontoxic to bone marrow stem cells. Long-lived, apparently immunologically vigorous, chimeras were achieved. Likewise, Truitt and Pollard (15) used germ-free donors and fatally irradiated germ-free recipient mice to create long-lived chimeras across major histocompatibility barriers. These animals have been found to be immunoincompetent in certain immunologic responses, but definition of these immunoincompetencies has been difficult because of uncertainty concerning the influence of GVHR or adjustments to GVHR.
Slavin et al. (16) have achieved a state of mixed chimerism using total nodal irradiation plus histoincompatible marrow transplantation. Reisner et al. (17) transplanted stem cells isolated from spleen, bone marrow, or thymus by agglutination and centrifugation after treatment in succession with soybean and peanut lectins and achieved long-lasting chimerism without producing GVHR. Thus far, in none of these models has precise composition of the chimeric state been defined or has comprehensive analysis of the immunocompetence of the chimeras been examined in light of the developing evidence of the restrictions imposed on immunologic functions by lack of histocompatibility of interacting cells (8, 9, (11) (12) (13) (14) (15) (16) (17) .
It seems especially important to pursue investigations of fully allogeneic chimeras because approaches to adoptive immunotherapy (18) may benefit from such analyses. In addition, hematopoietic transplantation across major histocompatibility barriers in man offers attractive potentialities for cellular engineering to treat inborn or acquired errors of hematopoiesis and abnormalities of immunologic function (19, 20) , and also offers the possibility of introducing resistance (R) genes for treatment and .prevention of occurrence of leukemias, lymphoid malignancies, and, perhaps, other cancers (15, 21) .
We report herein preparations of long-lived chimeras of AKR recipient and C57BL/ 6 (B6) donor mice using fatal total body irradiation plus injection of marrow that has been exposed in vitro to appropriate anti-Thy-l.2 antiserum in the absence of complement. When the marrow had been treated with this antiserum in vitro, virtually all the animals lived in good health for > 100 d after the transplant, and evidence of acute GVHR was not seen.
It is the purpose of this paper to present an analysis of the cellular makeup of the lymphoid tissues, and to evaluate hematopoietic and immunologic function of these radiation chimeras.
Materials and Methods
Animals. Inbred AKR/J, B6, BALB/cgl, and C3H/HeJ were obtained from The Jackson Laboratory, Bar Harbor, Maine. B6-H-2 congenic mice were a gift from Dr. F. W. Shen, Memorial Sloan-Kettering Cancer Center. (B6 × AKR)F1 and (B6 × BALB/c)F~ mice were bred in our colony.
Preparation of Bone Marrow Chimeras. Unless stated otherwise, female AKR mice, 15-wk old, were used as irradiated recipients of marrow cells. The mice were irradiated in a plastic box with 900 rads using a ~3VCs-y-irradiation source at a dose rate of 125 rads/min. 24 h after irradiation, these mice were given an intravenous injection of 25 × 106 B6 marrow cells treated in the following way: donor mice (female B6) were sacrificed by bleeding. Bone marrow cells were obtained from tibia and femur by gently flushing with cold RPMI-1640 supplemented with heat-inactivated fetal calf serum (FCS), 100 IU/ml penicillin, 100 #g/ml streptomycin, and glutamine (Grand Island Biological Co., Grand Island, N. Y.). After centrifugation, marrow suspensions were adjusted to 1 × 10S/ml and mixed with an equal volume of a 1:5 dilution of a potent anti-Thy-l.2 serum. The cells were incubated with the antiserum on ice for 30 min with occasional mixing, washed three times with medium, and injected intravenously into lethally irradiated recipients. Complement was not added to this preparation, and the treatment did not cause death of the cells at this point because there was no change in trypan blue dye exclusion.
As controls, 25 × 106 AKR syngeneic or 25 × 106 unmanipulated B6 marrow cells were injected into the irradiated AKR recipients. In some experiments lethally irradiated AKR or B6 mice were reconstituted with B6-H-2 k congenic mice (E k) or B6 marrow cells that had been treated with anti-Thy-l.2 serum alone, and irradiated B6 mice were given AKR marrow cells treated with anti-Thy-1.1 serum (1:5) without complement as described above.
All mice were given 400 mg/liter Terramycin (Pfizer Laboratories, Div. Pfizer Inc., New York) in their drinking water for 2 wk after irradiation. Thereafter, they were maintained on a conventional diet and given acidified water ad lib. The mice were observed daily for 100 d. Antisera. Anti-Thy-l.2 antiserum was prepared by injecting AKR/J female mice with 5 × 10 v C3H/HeJ thymus cells intraperitoneally at weekly intervals for 11 wk (22) . To remove autoantibody, the serum was absorbed with AKR thymus cells before use. The limiting titer of the anti-Thy-l.2 antiserum that gave 50% lysis of B6 thymocytes was between 1/1,600 and 1/ 3,200, and the titer of anti-Thy-1.1 serum, which was provided by Dr. F. W. Shen, as described below, gave 50% lysis of AKR thymocytes at a titer of I/1,280 and I/2,560. The following antisera were used in typing for H-2 and Thy-I phenotypes. Anti-Thy-l. anti-ASLl), anti-H-2 (E anti-EL-4), and anti-H-2 (hybridoma: 5R3). The antisera used were kindly provided by Doctors F. W. Shen, E. Nakayama, N. Tada, and U. Hiimmerling, Memorial Sloan-Kettering Cancer Center.
Determination of Lymphoid Cell Chimerism. All chimeras were maintained without further manipulation after hematopoietic reconstitution for 2.5-3.5 mo before analyses for chimerism and immunological functions. Chimerism was tested by analyzing spleen and thymus cells for susceptibility to cytolysis by the specific alloantisera mentioned above plus carefully selected rabbit or guinea pig complement. Typing for H-2 and Thy-1 surface antigens was performed by the cytotoxic test according to a modification of the method of Gofer and O'Gorman (23) . Dilutions of antisera used in cytotoxic tests are indicated in Table I , and, in this condition, >95% of relevant target cells and <5% of negative control cells were killed. The percentage of dead cells was evaluated by counting labeled cells after addition of 0.2% trypan blue dye. The cytotoxic index (CI) was determined according to the following formula: CI equals percent killed with antiserum + complement -percent killed in complement control × 100. 100 --percent killed in complement control
The spleen cell preparations used in each immunological assay were analyzed for H-2 phenotype and in every instance the chimeric spleen cell preparations contaned >95% cells of donor cell type.
Erythrocyte Antibody Complex (EA)-Rosette-forming Cell Assay. The proportion of the cells that possess a receptor for the Fc part ofIgG (FcR) was determined by EA-rosette-forming cell assay as described previously (24) . Briefly, sheep erythrocytes (E), sensitized with a subagglutinating dose of rabbit anti-sheep IgG (A) were mixed with spleen cells and incubated at 37°C for 5 rain. After overnight incubation at 4°C, the pellet was gently resuspended and mixed with crystal violet solution (medium 199 that contained 1% glutaraldehyde and 2% crystal violet). Stained cells found with three or more EA by light microscopic examination at × 100 were considered rosettes. The results were expressed as percentages of rosettes in relation to the total number of nucleated cells.
Simonsen's Splenomegaly Assay. The assay was performed according to the method by Simonsen (25) . The spleens from B6, [B6 ~ AKR) chimeras, and (B6 × AKR)F1 or (B6 × BALB/ c)Fx were gently homogenized and the viable cell concentration adjusted to 1 X 108/ml in medium 199 that contained 2% FCS. 1 × 10 7 spleen cells were then injected intraperitoneally into littermate 8-d-old (B6 × AKR)F1 or (B6 X BALB/c)Fa mice. 8 d later, both spleen-cell injected (experimental group) and medium injected (control group) were killed, their intact spleens removed and weighed, and the spleen index (SI) calculated (SI: spleen weight/body weight). GVHR index was detected according to the following formula: GVHR index ---SI in experimental group/SI in control group. Control mice were thus given a GVHR index of 1.0.
To Natural Killer (ARK) Cell Activity and Antibody-dependent Cell-mediated Cytotoxicity (ADCC). Spleens from each group of mice were collected in RPMI-1640 supplemented with 10% FCS (complete medium). The cells were released by gentle teasing in cold media, washed three times, and resuspended in complete medium to a concentration of 20 × 106/ml. Spleen cells from each group of mice to be compared were prepared similarly on the same day. RLc~I cells (radiation-induced leukemia in BALB/c strain) originally obtained from the National Institutes of Health (courtesy of Dr. R. Herberman) were used in NK assay. The NK activity was determined by a direct 5aCr-release method as previously described (27) .
The ADCC activity was determined by the method of Perlman as modified by Handwerger and Koren (28) . Briefly, 50/~1 of varying concentrations of effector cells was added to 50 #1 of RPMI-1640 that contained 104 5~Cr-labeled chicken erythrocytes (CRBC) and 100/~1 of a 1/ 10,000 final dilution of rabbit anti-CRBC antibodies. The plates were incubated for 3 h at 37°C in an atmosphere of 95% air and 5% CO2. The cytotoxicity was determined by a direct ~lCr-release method.
Response to In Vivo Immunization with Sheep Erythrocytes (SRBC).
Each mouse was injected intraperitoneally with 0.2 ml of a 10% suspension of SRBC (Grand Island Biological Co.). 4 d later the spleens were removed, gently homogenized, and the viable cell concentration adjusted tO 10 7 cells/ml to measure primary immune response by the plaque-forming cell (PFC) assay previously described (29) . To measure secondary immune response, mice were reimmunized 9 d after the first injection of SRBC and the PFC assay was carried out on day 13. To enumerate IgG PFC, rabbit anti-mouse IgG plus guinea pig complement was added in appropriate dilutions.
In one experiment, spleen cells were treated with anti-H-2 k antibody or anti-H-2 b serum and complement before incubating with SRBC on the culture plate (Table IV, footnote). 
Assay for Contact Sensitivity to 2,4-dinitro-l-fluorobenzene (DNFB) and

Results
Protection Against Lethal Irradiation by Allogeneic Marrow Transplantation with Marrow
Cells Treated with Anti-Thy-I Antiserum. Table I presents results comparing representative observations concerning body weight, thymus weight, numbers of spleen cells, proportions of spleen, and thymus cells bearing H-2 and Thy-1 surface antigens and Fc receptors. It will be seen from the table that the [B6 ~ AKR] chimeric mice were generally well developed and healthy according to their body weight and by all parameters compared favorably with irradiated mice reconstituted with syngeneic marrow. The numbers of spleen cells recoverable from the allogeneic chimeras were slightly decreased as compared with irradiated mice reconstituted with syngeneic marrow and untreated control mice of the same age. Thymus weight also was well maintained in these allogeneic chimeras. Allogeneic chimeras prepared with bone marrow that had not been treated with anti-Thy-1 antiserum regularly had only a minisucle thymus or the thymus could not be found. It can also be seen from this table that the long-lived [B6 ---> AKR] allogeneic chimeric mice prepared as described are regularly full (1 Table III 
Chimerism by Allogeneic Marrow Transplantation after Treatment with Anti-Thy-1 Antiserum without Complement.
Responses of Spleen Cells of[B6---* AKR] Chimeras to Mitogens.
NK Cell and ADCC Activities in [B6---* AKR] Chimeras. On
PFC Responses to In Vivo Stimulation with SRBC in [B6 ---* AKR] Chimeras.
To evaluate capacity for T-cell-dependent antibody production the response to SRBC after primary antigenic stimulation or secondary stimulation were studied. The results of these experiments are summarzed in Table IV To determine whether the secondary PFC responses in the [B6 ~ AKR] chimeras were reflecting an influence of AKR cells, the responses were compared in unmanipulated spleen cells and in spleen cells treated with anti-H-2 k or anti-H-2 b antibody plus complement. Such cytotoxic antibody treatment would eliminate all AKR cells or, alternatively, cells of the B6 donor origin (Table IV, footnote). The anti-H-2 k treatment failed completely to alter the capacity of the spleen cells of the chimeric mice to produce either direct or indirect plaques in the secondary response. By contrast, treatment with anti-H-2 b antiserum almost completely inhibited capacity to produce direct PFC and very much reduced capacity to form indirect PFC (Table   IV) .
Primary Responses to SRBC of Additional H-2-Compatible and -Incompatible
Combination. To determine whether the results presented in the previous section showing complete failure of primary immune response in [B6 ~ AKR] irradiation chimeras were a more general case and based upon genetic differences of donor and recipient at MHC, an additional set of experiments were performed. After lethal total body irradiation, mice of AKR or B6 strains were reconstituted by treatment with (Table V, footnote) . The results summarized in Table V show conclusively that in each instance when the bone marrow cells are from donors histocompatible with the recipients at the H-2 locus, the primary immune response shows numbers of both direct and indirect plaques equal to or approaching those of the unmanipulated B6 or AKR controls. In every instance where donor and recipient were incompatible at the H-2 locus, both direct and indirect plaque-forming responses were negligible. These findings supplement those of the prior experiment in establishing that in full chimeras the primary antibody response to thymus-dependent SRBC antigen requires histocompatibility at MHC between donor and recipient. 
Contact Sensitivity and Specific Unresponsiveness to Contact
Discussion
In these studies we present a reproducible method for preparing long-lived allogeneic chimeras where donor and recipient mice differ from one another across the major histocompatibility barrier, H-2. In the strain combination used, B6 donor and AKR recipient, which represents a strain combination with strong hybrid resistance to bone marrow transplantation (10) , the allogeneic chimeras [B6 ~ AKR] showed no evidence of GVHR when the marrow cells had been treated in vitro before injection by a potent anti-Thy-1.2 antisera in the absence of complement. By contrast, control mice given allogeneic marrow not so treated regularly survived longer than irradiated controls, but most of them died before 50 d with evidence of GVHR. From studies of the thymus and spleen ceils it could be shown that these chimei"ic AKR mice possessed virtually all B6 (H-2 b) lymphocytes but no cells with AKR (H-2 k) surface antigens. The Thy-l.2 antigen of the B6 donor T-cell type was present on the thymus cells, and an appropriate portion of the spleen cells and no evidence of Thy-1.1 (+) cells of AKR recipient origin could be demonstrated. Thus these were full chimeras. The [B6 ~ AKR] chimeras were shown to be tolerant of donor and recipient alloantigens by the Simonsen assay (25) and nearly fully reactive to third party alloantigens as revealed by the ability of their spleen cells to produce splenomegaly in (B6 × BALB/c)F1 recipients. However, a slightly diminished response toward third party antigens was seen (Fig. 2) , which may have been attributed to a small deficiency of T-cell numbers in the spleen (Table I) .
Interestingly, the tolerance observed appeared to be of classic type, probably based on clonal inhibition or deletion (31) and not on a suppressor cell mechanism because the spleen cells of these chimeras did not suppress the ability of the normal spleen cells from B6 or AKR donors to initiate GVHR in (B6 × AKR)F1 mice. To establish the absence of suppressor cells convincingly, further studies in search of suppressor cells function may be necessary in experiments that use higher proportions of the spleen cells from the chimeras, because in the analysis carried out here, only one ratio of the mixture of spleen cells from the chimera and normal B6 or AKR mice was used and a higher ratio might show evidence of suppressor cells, as reported by Urso and Gengozian (32) . In addition, other kinds of analyses (e.g., mixed lymphocytes reaction, cell-mediated lympholysis [33] ) of suppressor influence should also be carried out.
Spleen cells from these fully allogeneic chimeras were also able to demonstrate vigorous proliferative responses to PHA, Con A, and LPS stimulations in vitro. Thus, they had well-developed populations of both T and B lymphocytes that showed little or no evidence of being suppressed. Because some of these responses require T cell-T cell interactions (34) or interactions of T cells with cells of monocyte-macrophage lineage (35) , these chimeric mice appeared to have interaction of monocyte-macrophage lineage and the T lymphocytes sufficient to permit normal proliferative response to Con A, PHA, and LPS. This is, however, a somewhat controversial issue since McCombs et al. (36) reported that histocompatibility between lymphocyte and macrophage is not a requirement for proliferative responses to mitogens. NK and ADCC functions of these chimeric mice were also in normal range. (Table V) .
Thus, the primary responses in these fully chimeric mice where mature T cells have been eliminated from the precursors used for immunologic and hematopoietic reconstruction are deficient in T-dependent antibody formation as might be predicted from studies of genetic restriction previously reported (1, 2, 5, 37) . Nonetheless, strikingly vigorous responses of antibody-forming cells to the T-dependent antigen were observed for both IgM-and IgG-type plaque formation during a secondary response in the [B6 AKR] chimera (Table IV) . The indirect plaque formation was somewhat lower and the direct PFC responses considerably higher than were seen with the B6, AKR, or [AKR ~ AKR] controls. However, even the mice reconstituted after lethal total body irradiation by syngeneic marrow cells showed in the secondary response somewhat higher IgM plaques than did either donor or recipient strain. Thus, it would appear that although some degree of aliogeneic preference or restriction in indirect PFC response may be obtained in these chimeric mice, it is not as limiting with respect to secondary T-dependent antibody responses as might be extrapolated from the existing literature (1-3, 5, 6, 11-13, 37-39) . It seems to us that these findings are concordant with prior observations by Gengozian et al. The studies of CS in these fully allogeneic chimeras were also most fascinating. Skin reactions after sensitization with DNFB were not different from those of normal mice or of irradiated mice reconstituted with syngeneic bone marrow cells. This was somewhat surprising since Miller et al. (45) showed that identity at the MHC is necessary for passive transfer of delayed type hypersensitivity to DNFB and Asherson et al. (46) reported that active immunization with a small number of lymph node cells from donors immunized with contact sensitizer (oxazolone) 24 h before injection occurred only when a genetic matching at MHC between donor and recipient mice existed. These results, however, are also somewhat controversial, and our findings clearly indicate that vigorous CS to DNFB can occur when a state of full chimerism exists in which the lymphoid cells are of donor origin and the skin cells of host origin. Recent evidence suggests that Langerhans cells of the skin may play an important role in the development of CS because they can absorb certain antigens and possess Ia antigens and Fc receptors (47) (48) (49) . It thus seems important to know if in these chimeras the Langerhans cells are of donor or host origin. This should be studied.
By contrast to the observations with CS, desensitization, or tolerization by intravenous injection of DNBS was ineffectual in preventing CS to DNFB in these allogeneic chimeras but was fully effective in the lethally irradiated mice reconstituted with syngeneic or H-2-compatible marrow cells. Whether or not the rather complex tolerance in intact animals, which is known to depend in part on T-suppressor cells (50) , augmenting cells for the T-suppressor cells (51) , and even classical clonal inhibition (50, 52) can be developed in fully allogeneic chimeras by repeated stimulation with DNBS remains to be determined in future studies.
Because our experiments appear to lend an optimistic prespective to the possibility of cellular engineering (19) employing allogeneic cells differing from host across major histocompatibility barrier it will be of interest to know whether, in this model and in those employed by Miiller-Ruchholtz et al. (14) with rats, or that of Truitt and Pollard (15) with mice, truly long-lived [B6 ~ AKR] mice can be obtained that can resist bacterial and viral infections normally. Experiments to address these important questions with fully allogeneic chimeras seem in order. One would surely predict from the most recent experiments of Zinkernagel et al. (2, 3) 2 that the T lymphocyte developing in contact with the thymus epithelium of the recipients would be able to address the host-virus-infected somatic cells with normal immunologic vigor. It will be especially important to know whether allogeneic cells prepared with antiserum to eliminate T cells from marrow after a gentle manipulation, such as was used here, can resist the malignancies caused by virus or chemical carcinogens. The AKR recipients thus seem to be an especially good model for further inquiries into the effectiveness of the cellular and immunologic reconstitution after lethal irradiation and bone marrow transplantation made possible by treatment to eliminate post thymic cells with anti-Thy-1 serum in vitro.
Whether similar results will be obtained with other strain combinations in mice remains to be seen. Additional investigations in our own laboratories establish that long-lived, immunologically vigorous chimeras B6 --* CBA may be produced if the marrow cells are pretreated with appropriate anti-Thy-1 plus complement (S. Krown, R. Colco, G. Fernandes, and R. A. Good. Unpublished data.) This is the same genetic barrier studied in our experiments and is usually considered to be among the most resistant to allogeneic transplantation. Whether the preparatory treatment with anti-Thy-1 without complement has advantage over the preparatory treatment with antiThy-1 plus complement will have to be ascertained by direct comparative analyses of the two methods. That pretreatment with anti-Thy-1 serum without complement is effective, as shown herein, is of great importance because so many of the sources of complement one would like to use are also cytotoxic to the stem cells that one does not wish to damage. Summary AKR mice were protected from lethal irradiation and established as long-lived chimeras by transplanting allogeneic C57BL/6 (B6) bone marrow that had been treated in vitro with anti-Thy-1 antiserum without complement. In these chimeras, which were designated [B6 ~ AKR], virtually all the thymus and spleen cells were shown to be derived from the B6 donor; several immune functions studied in these chimeras were as follows: (a) The chimeric mice were tolerant of histocompatibility antigens of both donor and recipient strain and nearly fully reactive to antigens of third party, as revealed by Simonsen's splenomegaly assay. The tolerance of these chimeras could not be attributed to suppressor cells but was compatible with clonal depletion. These findings indicate that full chimeras across major histocompatibility complex have considerable immunologic vigor even though primary immune responses that require histocompatibility between interacting cell types are initially defective.
